Scribd Logo
Upload

Welcome to Scribd!

  • Top TenGlobal Pharmaceutical M&A Deals 2008

    Uploaded by

    routmanasranjan8219
    258 views1 page
    This document lists the top 10 largest mergers and acquisitions deals in the pharmaceutical industry by deal value, ranging from $43.7 billion for Genentech acquired by Roche to $1.1 billion for Sciele Pharma acquired by Shionogi. For each deal, it provides the target company, acquiring company, deal value in millions of dollars, and status of whether the deal is open or closed. The largest deals such as Genentech and Alcon remain open, while others such as Millennium Pharmaceuticals and ImClone Systems are closed.

    Original Description:

    Original Title

    Top TenGlobal Pharmaceutical M&A Deals 2008

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOC, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    This document lists the top 10 largest mergers and acquisitions deals in the pharmaceutical industry by deal value, ranging from $43.7 billion for Genentech acquired by Roche to $1.1 billion for Sciele Pharma acquired by Shionogi. For each deal, it provides the target company, acquiring company, deal value in millions of dollars, and status of whether the deal is open or closed. The largest deals such as Genentech and Alcon remain open, while others such as Millennium Pharmaceuticals and ImClone Systems are closed.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as doc, pdf, or txt
    258 views1 page

    Top TenGlobal Pharmaceutical M&A Deals 2008

    Uploaded by

    routmanasranjan8219
    This document lists the top 10 largest mergers and acquisitions deals in the pharmaceutical industry by deal value, ranging from $43.7 billion for Genentech acquired by Roche to $1.1 billion for Sciele Pharma acquired by Shionogi. For each deal, it provides the target company, acquiring company, deal value in millions of dollars, and status of whether the deal is open or closed. The largest deals such as Genentech and Alcon remain open, while others such as Millennium Pharmaceuticals and ImClone Systems are closed.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOC, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as doc, pdf, or txt
    of 1

    TargetCompany or M&A Deal

    Rank Deal Value($m) AcquiringCompany


    Business Unit Status
    1 Genentech 43700 Roche Open
    2 Alcon 10400 Novartis Open
    3 MillenniumPharmaceuticals 8800 Closed
    Takeda
    4 Barr Pharmaceuticals 7460 Teva Pharmaceutical Open
    Industries
    5 ImClone Systems 6500 Closed
    Eli Lilly
    6 Ranbaxy Laboratories 3950 Open
    Daiichi Sankyo
    7 Talecris Biotherapeutics 3100 Open
    CSL
    8 Zentiva 2590 Sanofi-Aventis Open
    9 Alpharma 1600 King Pharmaceuticals Open
    10 Sciele Pharma 1100 Shionogi Closed

    Prepared By: ManasRanjanRout


    Pharmaceutical & Healthcare Professional
    New Delhi
    Email: manasranjanrout4cv@gmail.com

    You might also like